FDA approves new COVID shots, with restrictions

Key takeaways:

The FDA approved updated COVID-19 vaccines for anyone aged 65 years or older.

The shots for children and adults aged 64 years or younger are approved with risk-based restrictions.

The FDA on Wednesday approved the updated COVID-19 vaccines for the 2025-2026 respiratory disease season, but with limitations not seen in previous years.

In a post on X, HHS Secretary Robert F. Kennedy Jr. announced that the updated shots made by Moderna, Pfizer and Novavax have been approved by the FDA for anyone aged 65 years or older.

The FDA has approved updated COVID-19 vaccines for people aged 65 years and older, while shots for people aged 64 years and younger come with risk-based restrictions. Image: Adobe Stock

Among children and younger adults, the shots are approved only f